MyAverix Finance
F · Healthcare
GENFIT S.A. ADR/1 EO-25 (XUPB)
Biotechnology
GENFIT S.A. ADR/1 EO-25 (XUPB) is listed on F in the Healthcare sector. Industry: Biotechnology. As of 2026-05-21, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for XUPB
GENFIT S.A. ADR/1 EO-25 (XUPB) — FAQ
What is XUPB's P/E ratio?
The price-to-earnings (P/E) ratio for GENFIT S.A. ADR/1 EO-25 (XUPB) is 25.00 (data as of 2026-05-21).
Does GENFIT S.A. ADR/1 EO-25 pay a dividend?
Dividend yield is not available in the current snapshot for GENFIT S.A. ADR/1 EO-25 (XUPB). Check the MyAverix Finance app for the latest dividend data.
What sector is GENFIT S.A. ADR/1 EO-25 in?
GENFIT S.A. ADR/1 EO-25 (XUPB) is classified in the Healthcare sector (Biotechnology industry).
What exchange is XUPB listed on?
XUPB is listed on F.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.